(STZ) Constellation Brands - Ratings and Ratios
Beer, Wine, Spirits
STZ EPS (Earnings per Share)
STZ Revenue
Description: STZ Constellation Brands
Constellation Brands Inc Class A (NYSE:STZ) is a leading producer, importer, and marketer of beer, wine, and spirits across multiple countries, including the United States, Canada, Mexico, New Zealand, and Italy. The companys diverse portfolio includes well-known beer brands such as Corona and Modelo, premium wine labels like Kim Crawford and The Prisoner Wine Company, and spirits brands including SVEDKA and Casa Noble.
From a business perspective, Constellation Brands has a significant presence in the global beverage alcohol market, with its products being distributed to wholesale distributors, retailers, on-premise locations, and state alcohol control agencies. The companys ability to cater to different markets and consumer preferences is a key strength, allowing it to maintain a competitive edge in the industry.
Some key performance indicators (KPIs) that can be used to evaluate Constellation Brands performance include revenue growth, gross margin, and operating cash flow. The companys ability to generate cash from operations is crucial in driving its business forward, including investing in marketing and brand development, as well as making strategic acquisitions to expand its portfolio. Additionally, metrics such as return on equity (ROE) and debt-to-equity ratio can provide insights into the companys financial health and leverage.
Given the current market conditions, its worth noting that Constellation Brands has a market capitalization of approximately $30.36 billion, with a forward price-to-earnings ratio of 13.46. While the companys ROE is currently negative, this may be a result of one-time events or industry-wide challenges. A closer examination of the companys financial statements and industry trends would be necessary to determine the underlying causes and potential areas for improvement.
STZ Stock Overview
Market Cap in USD | 25,210m |
Sub-Industry | Distillers & Vintners |
IPO / Inception | 1987-01-01 |
STZ Stock Ratings
Growth Rating | -61.4% |
Fundamental | 50.3% |
Dividend Rating | 61.6% |
Return 12m vs S&P 500 | -54.7% |
Analyst Rating | 3.96 of 5 |
STZ Dividends
Dividend Yield 12m | 2.57% |
Yield on Cost 5y | 2.34% |
Annual Growth 5y | 5.50% |
Payout Consistency | 100.0% |
Payout Ratio | 30.3% |
STZ Growth Ratios
Growth Correlation 3m | -44.5% |
Growth Correlation 12m | -84.1% |
Growth Correlation 5y | 15% |
CAGR 5y | -16.45% |
CAGR/Max DD 3y | -0.33 |
CAGR/Mean DD 3y | -1.51 |
Sharpe Ratio 12m | -1.72 |
Alpha | 0.00 |
Beta | 0.985 |
Volatility | 27.64% |
Current Volume | 2754.7k |
Average Volume 20d | 2754.7k |
Stop Loss | 128.6 (-3.3%) |
Signal | -1.44 |
Piotroski VR‑10 (Strict, 0-10) 5.5
Net Income (-442.3m TTM) > 0 and > 6% of Revenue (6% = 603.7m TTM) |
FCFTA 0.09 (>2.0%) and ΔFCFTA 3.77pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 2.46% (prev 6.99%; Δ -4.53pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.14 (>3.0%) and CFO 3.10b > Net Income -442.3m (YES >=105%, WARN >=100%) |
Net Debt (11.49b) to EBITDA (457.6m) ratio: 25.12 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.07 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (178.0m) change vs 12m ago -2.98% (target <= -2.0% for YES) |
Gross Margin 51.06% (prev 50.19%; Δ 0.87pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 41.64% (prev 38.79%; Δ 2.85pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 0.04 (EBITDA TTM 457.6m / Interest Expense TTM 409.2m) >= 6 (WARN >= 3) |
Altman Z'' 2.87
(A) 0.01 = (Total Current Assets 3.94b - Total Current Liabilities 3.69b) / Total Assets 22.26b |
(B) 0.58 = Retained Earnings (Balance) 12.94b / Total Assets 22.26b |
(C) 0.00 = EBIT TTM 17.0m / Avg Total Assets 24.16b |
(D) 0.86 = Book Value of Equity 12.63b / Total Liabilities 14.73b |
Total Rating: 2.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 50.25
1. Piotroski 5.50pt = 0.50 |
2. FCF Yield 5.63% = 2.82 |
3. FCF Margin 20.55% = 5.14 |
4. Debt/Equity 1.59 = 1.35 |
5. Debt/Ebitda 25.28 = -2.50 |
6. ROIC - WACC (= -6.77)% = -8.46 |
7. RoE -5.93% = -0.99 |
8. Rev. Trend 14.14% = 1.06 |
9. EPS Trend 26.66% = 1.33 |
What is the price of STZ shares?
Over the past week, the price has changed by -6.90%, over one month by -19.98%, over three months by -16.66% and over the past year by -46.24%.
Is Constellation Brands a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of STZ is around 114.50 USD . This means that STZ is currently overvalued and has a potential downside of -13.94%.
Is STZ a buy, sell or hold?
- Strong Buy: 9
- Buy: 7
- Hold: 10
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the STZ price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 182 | 36.8% |
Analysts Target Price | 182 | 36.8% |
ValueRay Target Price | 125.8 | -5.5% |
Last update: 2025-09-13 04:42
STZ Fundamental Data Overview
CCE Cash And Equivalents = 73.9m USD (last quarter)
P/E Forward = 12.2249
P/S = 2.5055
P/B = 3.4693
P/EG = 1.5758
Beta = 0.669
Revenue TTM = 10.06b USD
EBIT TTM = 17.0m USD
EBITDA TTM = 457.6m USD
Long Term Debt = 9.79b USD (from longTermDebt, last quarter)
Short Term Debt = 1.78b USD (from shortTermDebt, last quarter)
Debt = 11.57b USD (Calculated: Short Term 1.78b + Long Term 9.79b)
Net Debt = 11.49b USD (from netDebt column, last quarter)
Enterprise Value = 36.70b USD (25.21b + Debt 11.57b - CCE 73.9m)
Interest Coverage Ratio = 0.04 (Ebit TTM 17.0m / Interest Expense TTM 409.2m)
FCF Yield = 5.63% (FCF TTM 2.07b / Enterprise Value 36.70b)
FCF Margin = 20.55% (FCF TTM 2.07b / Revenue TTM 10.06b)
Net Margin = -4.40% (Net Income TTM -442.3m / Revenue TTM 10.06b)
Gross Margin = 51.06% ((Revenue TTM 10.06b - Cost of Revenue TTM 4.92b) / Revenue TTM)
Tobins Q-Ratio = 2.91 (Enterprise Value 36.70b / Book Value Of Equity 12.63b)
Interest Expense / Debt = 0.87% (Interest Expense 100.6m / Debt 11.57b)
Taxrate = 14.33% (87.6m / 611.4m)
NOPAT = 14.6m (EBIT 17.0m * (1 - 14.33%))
Current Ratio = 1.07 (Total Current Assets 3.94b / Total Current Liabilities 3.69b)
Debt / Equity = 1.59 (Debt 11.57b / last Quarter total Stockholder Equity 7.27b)
Debt / EBITDA = 25.28 (Net Debt 11.49b / EBITDA 457.6m)
Debt / FCF = 5.60 (Debt 11.57b / FCF TTM 2.07b)
Total Stockholder Equity = 7.46b (last 4 quarters mean)
RoA = -1.99% (Net Income -442.3m, Total Assets 22.26b )
RoE = -5.93% (Net Income TTM -442.3m / Total Stockholder Equity 7.46b)
RoCE = 0.10% (Ebit 17.0m / (Equity 7.46b + L.T.Debt 9.79b))
RoIC = 0.08% (NOPAT 14.6m / Invested Capital 19.02b)
WACC = 6.84% (E(25.21b)/V(36.78b) * Re(9.64%)) + (D(11.57b)/V(36.78b) * Rd(0.87%) * (1-Tc(0.14)))
Shares Correlation 3-Years: -90.91 | Cagr: -0.35%
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 72.53% ; FCFE base≈1.82b ; Y1≈1.80b ; Y5≈1.88b
Fair Price DCF = 144.3 (DCF Value 25.43b / Shares Outstanding 176.3m; 5y FCF grow -1.46% → 3.0% )
EPS Correlation: 26.66 | EPS CAGR: 0.57% | SUE: -0.51 | # QB: 0
Revenue Correlation: 14.14 | Revenue CAGR: 1.27% | SUE: N/A | # QB: None
Additional Sources for STZ Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle